Adenovirus early region 3 (E3) immunomodulatory genes decrease the incidence of autoimmune diabetes in NOD mice

被引:27
作者
Efrat, S
Serreze, D
Svetlanov, A
Post, CM
Johnson, EA
Herold, K
Horwitz, M
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel
[3] Jackson Lab, Bar Harbor, ME 04609 USA
[4] Columbia Univ, Coll Phys & Surg, Dept Med, New York, NY USA
[5] Columbia Univ, Coll Phys & Surg, Naomi Berrie Diabet Ctr, New York, NY USA
关键词
D O I
10.2337/diabetes.50.5.980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The early three (E3) region of the adenovirus (Ad) encodes a number of immunomodulatory proteins that interfere with class I major histocompatibility-mediated antigen presentation and confer resistance to cytokine-induced apoptosis in cells infected by the virus. Transgenic expression of Ad E3 genes under the rat insulin II promoter (RIP-E3) in beta -cells in nonobese diabetic (NOD) mice decreases the incidence and delays the onset of autoimmune diabetes. The immune effector cells of RTP-E3/NOD mice maintain the ability to infiltrate the islets and transfer diabetes into NOD-scid recipients, although at a significantly reduced rate compared with wild-type littermates. The islets of RIP-E3/NOD mice can be destroyed by adoptive transfer of splenocytes from wild-type NOD mice; however, the time to onset of hyperglycemia is delayed significantly, and 40% of these recipients mere not diabetic at the end of the experiment. These findings suggest that expression of E3 genes in beta -cells affects both the activation of immune effector cells and the intrinsic resistance of beta -cells to autoimmune destruction.
引用
收藏
页码:980 / 984
页数:5
相关论文
共 27 条
[1]  
Bennett EM, 1999, J IMMUNOL, V162, P5049
[2]   TYPE-I DIABETES - A CHRONIC AUTOIMMUNE-DISEASE OF HUMAN, MOUSE, AND RAT [J].
CASTANO, L ;
EISENBARTH, GS .
ANNUAL REVIEW OF IMMUNOLOGY, 1990, 8 :647-679
[3]   PROLONGED SURVIVAL OF PANCREATIC-ISLET ALLOGRAFTS MEDIATED BY ADENOVIRUS IMMUNOREGULATORY TRANSGENES [J].
EFRAT, S ;
FEJER, G ;
BROWNLEE, M ;
HORWITZ, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (15) :6947-6951
[4]   Prospects for gene therapy of insulin-dependent diabetes mellitus [J].
Efrat, S .
DIABETOLOGIA, 1998, 41 (12) :1401-1409
[5]   The temporal importance of TNFα expression in the development of diabetes [J].
Green, EA ;
Flavell, RA .
IMMUNITY, 2000, 12 (05) :459-469
[6]   Local expression of TNFα in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens [J].
Green, EA ;
Eynon, EE ;
Flavell, RA .
IMMUNITY, 1998, 9 (05) :733-743
[7]   T-CELL TOLERANCE TOWARD A TRANSGENIC BETA-CELL ANTIGEN AND TRANSCRIPTION OF ENDOGENOUS PANCREATIC GENES IN THYMUS [J].
JOLICOEUR, C ;
HANAHAN, D ;
SMITH, KM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6707-6711
[8]   THE MURINE AUTOIMMUNE DIABETES MODEL - NOD AND RELATED STRAINS [J].
KIKUTANI, H ;
MAKINO, S .
ADVANCES IN IMMUNOLOGY, 1992, 51 :285-322
[9]   Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues [J].
Lenzen, S ;
Drinkgern, J ;
Tiedge, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1996, 20 (03) :463-466
[10]   Identification of a cell protein (FIP-3) as a modulator of NF-κB activity and as a target of an adenovirus inhibitor of tumor necrosis factor α-induced apoptosis [J].
Li, YG ;
Kang, J ;
Friedman, J ;
Tarassishin, L ;
Ye, JJ ;
Kovalenko, A ;
Wallach, D ;
Horwitz, MS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1042-1047